NewsBenzingaPepGen、PGN-EDODM1の第2相FREEDOM2-DM1試験データを発表、平均スプライシング補正率46.5%を示す;PGN-EDODM1は高い忍容性を示した; PepGen、PGN-EDODM1の第2相FREEDOM2-DM1試験データを発表、平均スプライシング補正率46.5%を示す;PGN-EDODM1は高い忍容性を示した; Benzinga 2026.11.10 12:07 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Commercial Metals, Lowers Price Target to $63 Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37 If You Invested $100 In Cenovus Energy Stock 5 Years Ago, You Would Have This Much Today Wells Fargo Maintains Overweight on Cleveland-Cliffs, Raises Price Target to $18 TD Cowen Maintains Buy on BWX Technologies, Lowers Price Target to $180